메뉴 건너뛰기




Volumn 9, Issue 10, 2015, Pages 1918-1935

Tumor-infiltrating lymphocytes for the treatment of metastatic cancer

Author keywords

Adoptive cell transfer; Interleukin 2; Lymphodepletion; Melanoma; Tumor infiltrating lymphocytes

Indexed keywords

INTERLEUKIN 2; TUMOR ANTIGEN;

EID: 84952637287     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.10.018     Document Type: Review
Times cited : (92)

References (116)
  • 4
    • 0025859335 scopus 로고
    • Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer
    • Aoki Y., Takakuwa K., Kodama S., Tanaka K., Takahashi M., Tokunaga A., Takahashi T. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer. Cancer Res. 1991, 51:1934-1939.
    • (1991) Cancer Res. , vol.51 , pp. 1934-1939
    • Aoki, Y.1    Takakuwa, K.2    Kodama, S.3    Tanaka, K.4    Takahashi, M.5    Tokunaga, A.6    Takahashi, T.7
  • 7
    • 84928763657 scopus 로고    scopus 로고
    • Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma
    • Baldan V., Griffiths R., Hawkins R.E., Gilham D.E. Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma. Br. J. Cancer 2015, 112:1510-1518.
    • (2015) Br. J. Cancer , vol.112 , pp. 1510-1518
    • Baldan, V.1    Griffiths, R.2    Hawkins, R.E.3    Gilham, D.E.4
  • 8
    • 84892946785 scopus 로고    scopus 로고
    • Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
    • Balermpas P., Michel Y., Wagenblast J., Seitz O., Weiss C., Rodel F., Rodel C., Fokas E. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br. J. Cancer 2014, 110:501-509.
    • (2014) Br. J. Cancer , vol.110 , pp. 501-509
    • Balermpas, P.1    Michel, Y.2    Wagenblast, J.3    Seitz, O.4    Weiss, C.5    Rodel, F.6    Rodel, C.7    Fokas, E.8
  • 10
    • 0018906201 scopus 로고
    • T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor
    • Berendt M.J., North R.J. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J. Exp. Med. 1980, 151:69-80.
    • (1980) J. Exp. Med. , vol.151 , pp. 69-80
    • Berendt, M.J.1    North, R.J.2
  • 11
    • 0016531488 scopus 로고
    • Syngeneic adoptive immunotherapy and chemoimmunotherapy of a friend leukemia: requirement for T cells
    • Berenson J.R., Einstein A.B., Fefer A. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a friend leukemia: requirement for T cells. J. Immunol. 1975, 115:234-238.
    • (1975) J. Immunol. , vol.115 , pp. 234-238
    • Berenson, J.R.1    Einstein, A.B.2    Fefer, A.3
  • 13
    • 0018187313 scopus 로고
    • In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors
    • Blazar B.A., Heppner G.H. In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors. J. Immunol. 1978, 120:1876-1880.
    • (1978) J. Immunol. , vol.120 , pp. 1876-1880
    • Blazar, B.A.1    Heppner, G.H.2
  • 15
    • 84890277186 scopus 로고    scopus 로고
    • Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy
    • Chacon J.A., Pilon-Thomas S., Sarnaik A.A., Radvanyi L.G. Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy. Oncoimmunology 2013, 2:e25581.
    • (2013) Oncoimmunology , vol.2
    • Chacon, J.A.1    Pilon-Thomas, S.2    Sarnaik, A.A.3    Radvanyi, L.G.4
  • 17
    • 84936941924 scopus 로고    scopus 로고
    • A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens
    • Chalopin B., Florenceau L., Fradin D., Labarriere N., Moreau-Aubry A. A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens. Melanoma Res. 2015, 25:279-283.
    • (2015) Melanoma Res. , vol.25 , pp. 279-283
    • Chalopin, B.1    Florenceau, L.2    Fradin, D.3    Labarriere, N.4    Moreau-Aubry, A.5
  • 19
    • 0018934336 scopus 로고
    • Specificity of adoptive chemoimmunotherapy of established syngeneic tumors
    • Cheever M.A., Greenberg P.D., Fefer A. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors. J. Immunol. 1980, 125:711-714.
    • (1980) J. Immunol. , vol.125 , pp. 711-714
    • Cheever, M.A.1    Greenberg, P.D.2    Fefer, A.3
  • 20
    • 0032499710 scopus 로고    scopus 로고
    • Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
    • Chen Y.T., Gure A.O., Tsang S., Stockert E., Jager E., Knuth A., Old L.J. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6919-6923.
    • (1998) Proc. Natl. Acad. Sci. U. S. A. , vol.95 , pp. 6919-6923
    • Chen, Y.T.1    Gure, A.O.2    Tsang, S.3    Stockert, E.4    Jager, E.5    Knuth, A.6    Old, L.J.7
  • 21
    • 0029925375 scopus 로고    scopus 로고
    • Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
    • Clemente C.G., Mihm M.C., Bufalino R., Zurrida S., Collini P., Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996, 77:1303-1310.
    • (1996) Cancer , vol.77 , pp. 1303-1310
    • Clemente, C.G.1    Mihm, M.C.2    Bufalino, R.3    Zurrida, S.4    Collini, P.5    Cascinelli, N.6
  • 23
    • 0037829421 scopus 로고    scopus 로고
    • Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
    • Dudley M.E., Wunderlich J.R., Shelton T.E., Even J., Rosenberg S.A. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J. Immunother. 2003, 26:332-342.
    • (2003) J. Immunother. , vol.26 , pp. 332-342
    • Dudley, M.E.1    Wunderlich, J.R.2    Shelton, T.E.3    Even, J.4    Rosenberg, S.A.5
  • 28
    • 0019969717 scopus 로고
    • Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2
    • Eberlein T.J., Rosenstein M., Rosenberg S.A. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. J. Exp. Med. 1982, 156:385-397.
    • (1982) J. Exp. Med. , vol.156 , pp. 385-397
    • Eberlein, T.J.1    Rosenstein, M.2    Rosenberg, S.A.3
  • 30
    • 0036812718 scopus 로고    scopus 로고
    • Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy
    • Engelhard V.H., Bullock T.N., Colella T.A., Sheasley S.L., Mullins D.W. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol. Rev. 2002, 188:136-146.
    • (2002) Immunol. Rev. , vol.188 , pp. 136-146
    • Engelhard, V.H.1    Bullock, T.N.2    Colella, T.A.3    Sheasley, S.L.4    Mullins, D.W.5
  • 31
    • 0029682320 scopus 로고    scopus 로고
    • Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes
    • Freedman R.S., Platsoucas C.D. Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes. Cancer Treat. Res. 1996, 82:115-146.
    • (1996) Cancer Treat. Res. , vol.82 , pp. 115-146
    • Freedman, R.S.1    Platsoucas, C.D.2
  • 32
    • 84858800620 scopus 로고    scopus 로고
    • The immune contexture in human tumours: impact on clinical outcome
    • Fridman W.H., Pages F., Sautes-Fridman C., Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 2012, 12:298-306.
    • (2012) Nat. Rev. Cancer , vol.12 , pp. 298-306
    • Fridman, W.H.1    Pages, F.2    Sautes-Fridman, C.3    Galon, J.4
  • 34
    • 0029049890 scopus 로고
    • Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes
    • Fujita K., Ikarashi H., Takakuwa K., Kodama S., Tokunaga A., Takahashi T., Tanaka K. Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Clin. Cancer Res. 1995, 1:501-507.
    • (1995) Clin. Cancer Res. , vol.1 , pp. 501-507
    • Fujita, K.1    Ikarashi, H.2    Takakuwa, K.3    Kodama, S.4    Tokunaga, A.5    Takahashi, T.6    Tanaka, K.7
  • 38
    • 79959745851 scopus 로고    scopus 로고
    • The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
    • Gooden M.J., de Bock G.H., Leffers N., Daemen T., Nijman H.W. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br. J. Cancer 2011, 105:93-103.
    • (2011) Br. J. Cancer , vol.105 , pp. 93-103
    • Gooden, M.J.1    de Bock, G.H.2    Leffers, N.3    Daemen, T.4    Nijman, H.W.5
  • 43
    • 17844381006 scopus 로고    scopus 로고
    • Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
    • Huang J., Khong H.T., Dudley M.E., El-Gamil M., Li Y.F., Rosenberg S.A., Robbins P.F. Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J. Immunother. 2005, 28:258-267.
    • (2005) J. Immunother. , vol.28 , pp. 258-267
    • Huang, J.1    Khong, H.T.2    Dudley, M.E.3    El-Gamil, M.4    Li, Y.F.5    Rosenberg, S.A.6    Robbins, P.F.7
  • 44
    • 33744940000 scopus 로고    scopus 로고
    • Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy
    • Huang J., Kerstann K.W., Ahmadzadeh M., Li Y.F., El-Gamil M., Rosenberg S.A., Robbins P.F. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J. Immunol. 2006, 176:7726-7735.
    • (2006) J. Immunol. , vol.176 , pp. 7726-7735
    • Huang, J.1    Kerstann, K.W.2    Ahmadzadeh, M.3    Li, Y.F.4    El-Gamil, M.5    Rosenberg, S.A.6    Robbins, P.F.7
  • 45
    • 84856021596 scopus 로고    scopus 로고
    • Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis
    • Hwang W.T., Adams S.F., Tahirovic E., Hagemann I.S., Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol. Oncol. 2012, 124:192-198.
    • (2012) Gynecol. Oncol. , vol.124 , pp. 192-198
    • Hwang, W.T.1    Adams, S.F.2    Tahirovic, E.3    Hagemann, I.S.4    Coukos, G.5
  • 49
    • 0031406876 scopus 로고    scopus 로고
    • Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
    • Keilholz U., Stoter G., Punt C.J., Scheibenbogen C., Lejeune F., Eggermont A.M. Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. Cancer J. Sci. Am. 1997, 3(Suppl. 1):S22-S28.
    • (1997) Cancer J. Sci. Am. , vol.3 , pp. S22-S28
    • Keilholz, U.1    Stoter, G.2    Punt, C.J.3    Scheibenbogen, C.4    Lejeune, F.5    Eggermont, A.M.6
  • 50
    • 84868255419 scopus 로고    scopus 로고
    • Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?
    • KlebanoffC.A., Gattinoni L., Restifo N.P. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?. J. Immunother. 2012, 35:651-660.
    • (2012) J. Immunother. , vol.35 , pp. 651-660
    • Klebanoff, C.A.1    Gattinoni, L.2    Restifo, N.P.3
  • 54
    • 73949086540 scopus 로고    scopus 로고
    • MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro
    • Li Y., Liu S., Hernandez J., Vence L., Hwu P., Radvanyi L. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro. J. Immunol. 2010, 184:452-465.
    • (2010) J. Immunol. , vol.184 , pp. 452-465
    • Li, Y.1    Liu, S.2    Hernandez, J.3    Vence, L.4    Hwu, P.5    Radvanyi, L.6
  • 61
    • 0023093741 scopus 로고
    • Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma
    • Muul L.M., Spiess P.J., Director E.P., Rosenberg S.A. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 1987, 138:989-995.
    • (1987) J. Immunol. , vol.138 , pp. 989-995
    • Muul, L.M.1    Spiess, P.J.2    Director, E.P.3    Rosenberg, S.A.4
  • 62
    • 0020047427 scopus 로고
    • Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells
    • North R.J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J. Exp. Med. 1982, 155:1063-1074.
    • (1982) J. Exp. Med. , vol.155 , pp. 1063-1074
    • North, R.J.1
  • 66
    • 11144241310 scopus 로고    scopus 로고
    • Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
    • Powell D.J., Dudley M.E., Robbins P.F., Rosenberg S.A. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 2005, 105:241-250.
    • (2005) Blood , vol.105 , pp. 241-250
    • Powell, D.J.1    Dudley, M.E.2    Robbins, P.F.3    Rosenberg, S.A.4
  • 67
    • 77953044135 scopus 로고    scopus 로고
    • Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy
    • Prieto P.A., Durflinger K.H., Wunderlich J.R., Rosenberg S.A., Dudley M.E. Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy. J. Immunother. 2010, 33:547-556.
    • (2010) J. Immunother. , vol.33 , pp. 547-556
    • Prieto, P.A.1    Durflinger, K.H.2    Wunderlich, J.R.3    Rosenberg, S.A.4    Dudley, M.E.5
  • 69
    • 0028363683 scopus 로고
    • Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy
    • Robbins P.F., el-Gamil M., Kawakami Y., Stevens E., Yannelli J.R., Rosenberg S.A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 1994, 54:3124-3126.
    • (1994) Cancer Res. , vol.54 , pp. 3124-3126
    • Robbins, P.F.1    el-Gamil, M.2    Kawakami, Y.3    Stevens, E.4    Yannelli, J.R.5    Rosenberg, S.A.6
  • 70
    • 0029669950 scopus 로고    scopus 로고
    • A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
    • Robbins P.F., El-Gamil M., Li Y.F., Kawakami Y., Loftus D., Appella E., Rosenberg S.A. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 1996, 183:1185-1192.
    • (1996) J. Exp. Med. , vol.183 , pp. 1185-1192
    • Robbins, P.F.1    El-Gamil, M.2    Li, Y.F.3    Kawakami, Y.4    Loftus, D.5    Appella, E.6    Rosenberg, S.A.7
  • 71
    • 0037111530 scopus 로고    scopus 로고
    • Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
    • Robbins P.F., El-Gamil M., Li Y.F., Zeng G., Dudley M., Rosenberg S.A. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J. Immunol. 2002, 169:6036-6047.
    • (2002) J. Immunol. , vol.169 , pp. 6036-6047
    • Robbins, P.F.1    El-Gamil, M.2    Li, Y.F.3    Zeng, G.4    Dudley, M.5    Rosenberg, S.A.6
  • 78
    • 0022473607 scopus 로고
    • A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
    • Rosenberg S.A., Spiess P., Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986, 233:1318-1321.
    • (1986) Science , vol.233 , pp. 1318-1321
    • Rosenberg, S.A.1    Spiess, P.2    Lafreniere, R.3
  • 80
    • 0032471712 scopus 로고    scopus 로고
    • Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response
    • Rosenberg S.A., Yang J.C., White D.E., Steinberg S.M. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann. Surg. 1998, 228:307-319.
    • (1998) Ann. Surg. , vol.228 , pp. 307-319
    • Rosenberg, S.A.1    Yang, J.C.2    White, D.E.3    Steinberg, S.M.4
  • 83
    • 0036813331 scopus 로고    scopus 로고
    • Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
    • Scanlan M.J., Gure A.O., Jungbluth A.A., Old L.J., Chen Y.T. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunolog. Rev. 2002, 188:22-32.
    • (2002) Immunolog. Rev. , vol.188 , pp. 22-32
    • Scanlan, M.J.1    Gure, A.O.2    Jungbluth, A.A.3    Old, L.J.4    Chen, Y.T.5
  • 85
    • 0030851392 scopus 로고    scopus 로고
    • Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy
    • Schendel D.J., Oberneder R., Falk C.S., Jantzer P., Kressenstein S., Maget B., Hofstetter A., Riethmuller G., Nossner E. Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy. J. Mol. Med. 1997, 75:400-413.
    • (1997) J. Mol. Med. , vol.75 , pp. 400-413
    • Schendel, D.J.1    Oberneder, R.2    Falk, C.S.3    Jantzer, P.4    Kressenstein, S.5    Maget, B.6    Hofstetter, A.7    Riethmuller, G.8    Nossner, E.9
  • 86
    • 84928770388 scopus 로고    scopus 로고
    • Neoantigens in cancer immunotherapy
    • Schumacher T.N., Schreiber R.D. Neoantigens in cancer immunotherapy. Science 2015, 348:69-74.
    • (2015) Science , vol.348 , pp. 69-74
    • Schumacher, T.N.1    Schreiber, R.D.2
  • 87
    • 0036836168 scopus 로고    scopus 로고
    • Managing toxicities of high-dose interleukin-2
    • Schwartz R.N., Stover L., Dutcher J. Managing toxicities of high-dose interleukin-2. Oncology 2002, 16:11-20.
    • (2002) Oncology , vol.16 , pp. 11-20
    • Schwartz, R.N.1    Stover, L.2    Dutcher, J.3
  • 89
    • 70350716447 scopus 로고    scopus 로고
    • T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective
    • Shablak A., Hawkins R.E., Rothwell D.G., Elkord E. T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective. Clin. Cancer Res. 2009, 15:6503-6510.
    • (2009) Clin. Cancer Res. , vol.15 , pp. 6503-6510
    • Shablak, A.1    Hawkins, R.E.2    Rothwell, D.G.3    Elkord, E.4
  • 90
    • 0023640856 scopus 로고
    • In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2
    • Spiess P.J., Yang J.C., Rosenberg S.A. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. J. Natl. Cancer Inst. 1987, 79:1067-1075.
    • (1987) J. Natl. Cancer Inst. , vol.79 , pp. 1067-1075
    • Spiess, P.J.1    Yang, J.C.2    Rosenberg, S.A.3
  • 93
    • 0023252348 scopus 로고
    • Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials
    • Topalian S.L., Muul L.M., Solomon D., Rosenberg S.A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods 1987, 102:127-141.
    • (1987) J. Immunol. Methods , vol.102 , pp. 127-141
    • Topalian, S.L.1    Muul, L.M.2    Solomon, D.3    Rosenberg, S.A.4
  • 98
    • 84883433341 scopus 로고    scopus 로고
    • Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy
    • Turcotte S., Gros A., Hogan K., Tran E., Hinrichs C.S., Wunderlich J.R., Dudley M.E., Rosenberg S.A. Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy. J. Immunol. 2013, 191:2217-2225.
    • (2013) J. Immunol. , vol.191 , pp. 2217-2225
    • Turcotte, S.1    Gros, A.2    Hogan, K.3    Tran, E.4    Hinrichs, C.S.5    Wunderlich, J.R.6    Dudley, M.E.7    Rosenberg, S.A.8
  • 100
    • 0036780666 scopus 로고    scopus 로고
    • Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model
    • Tuthill R.J., Unger J.M., Liu P.Y., Flaherty L.E., Sondak V.K., Southwest Oncology G. Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model. Am. J. Clin. Pathol. 2002, 118:504-511.
    • (2002) Am. J. Clin. Pathol. , vol.118 , pp. 504-511
    • Tuthill, R.J.1    Unger, J.M.2    Liu, P.Y.3    Flaherty, L.E.4    Sondak, V.K.5    Southwest Oncology, G.6
  • 105
    • 84870352830 scopus 로고    scopus 로고
    • Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma
    • Wang Q.J., Hanada K., Robbins P.F., Li Y.F., Yang J.C. Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma. Cancer Res. 2012, 72:6119-6129.
    • (2012) Cancer Res. , vol.72 , pp. 6119-6129
    • Wang, Q.J.1    Hanada, K.2    Robbins, P.F.3    Li, Y.F.4    Yang, J.C.5
  • 108
    • 84962020040 scopus 로고    scopus 로고
    • PD-1 and CD103 are widely co-expressed on prognostically favorable intraepithelial CD8 T cells in human ovarian cancer
    • Webb J.R., Milne K., Nelson B.H. PD-1 and CD103 are widely co-expressed on prognostically favorable intraepithelial CD8 T cells in human ovarian cancer. Cancer Immunol. Res. 2015, 3:926-935.
    • (2015) Cancer Immunol. Res. , vol.3 , pp. 926-935
    • Webb, J.R.1    Milne, K.2    Nelson, B.H.3
  • 112
    • 84862490985 scopus 로고    scopus 로고
    • Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
    • Yao X., Ahmadzadeh M., Lu Y.C., Liewehr D.J., Dudley M.E., Liu F., Schrump D.S., Steinberg S.M., Rosenberg S.A., Robbins P.F. Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. Blood 2012, 119:5688-5696.
    • (2012) Blood , vol.119 , pp. 5688-5696
    • Yao, X.1    Ahmadzadeh, M.2    Lu, Y.C.3    Liewehr, D.J.4    Dudley, M.E.5    Liu, F.6    Schrump, D.S.7    Steinberg, S.M.8    Rosenberg, S.A.9    Robbins, P.F.10
  • 114
    • 0015877691 scopus 로고
    • Separation of lymphocytes from disaggregated mouse malignant neoplasms by sedimentation in gradients of ficoll in tissue culture medium
    • Zettergren J.G., LuberoffD.E., Pretlow T.G. Separation of lymphocytes from disaggregated mouse malignant neoplasms by sedimentation in gradients of ficoll in tissue culture medium. J. Immunol. 1973, 111:836-840.
    • (1973) J. Immunol. , vol.111 , pp. 836-840
    • Zettergren, J.G.1    Luberoff, D.E.2    Pretlow, T.G.3
  • 116
    • 84933564607 scopus 로고    scopus 로고
    • Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer
    • Zsiros E., Tsuji T., Odunsi K. Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer. J. Clin. Oncol. 2015, 33:1521-1522.
    • (2015) J. Clin. Oncol. , vol.33 , pp. 1521-1522
    • Zsiros, E.1    Tsuji, T.2    Odunsi, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.